Ekso Bionics Holdings Inc
F:23E2
Relative Value
The Relative Value of one
Ekso Bionics Holdings Inc
stock under the Base Case scenario is
5.144
EUR.
Compared to the current market price of 3.315 EUR,
Ekso Bionics Holdings Inc
is
Undervalued by 36%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Ekso Bionics Holdings Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Ekso Bionics Holdings Inc
F:23E2
|
33.8m EUR | 2.5 | -3.4 | -3.8 | -3.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
194.9B USD | 4.4 | 29.9 | 16.9 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.4 | 47.6 | 57.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.7B USD | 5.5 | 42.7 | 21.7 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.4B USD | 3.8 | 27.4 | 15.3 | 22.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.1B USD | 5.7 | 39.5 | 23.5 | 32 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.3B EUR | 2 | 21.8 | 12 | 17 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.9 | 34.9 | 38.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.9B USD | 2.2 | 29.2 | 11.2 | 19 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD | 7.6 | 32.8 | 23.3 | 25.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
38.7B USD | 7.2 | 26.1 | 18.4 | 20.5 |